01 7Arimidex
02 2Arimidex
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 185
2019 Revenue in Millions : 225
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 139
2020 Revenue in Millions : 185
Growth (%) : -25
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 99
2021 Revenue in Millions : 139
Growth (%) : -29
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 298
2014 Revenue in Millions : 250
Growth (%) : -16%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 217
2016 Revenue in Millions : 232
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -15.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 212
2017 Revenue in Millions : 217
Growth (%) : -2%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 232
2015 Revenue in Millions : 250
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 225
2018 Revenue in Millions : 212
Growth (%) : 6
LOOKING FOR A SUPPLIER?